Evidence map›Paper›PMID 40156000›Full record

ArticleBMC chemistry2025

The potential of novel arsenic nanoparticles containing metformin (MTF@As NPs): a study on their antioxidant and cytotoxic properties.

Mojtaba Shakibaie, Seyed Soheil Hosseininasab, Soudabe Riahi-Madvar, Mahboubeh Adeli-Sardou, Fereshteh Jabari-Morouei, Hamid Forootanfar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mojtaba ShakibaiePharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Seyed Soheil HosseininasabThe Student Research Committee, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran.
Soudabe Riahi-MadvarPharmaceutical Sciences and Cosmetic Products Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Mahboubeh Adeli-SardouDepartment of Biotechnology, Institute of Science and High Technology and Environmental Sciences, Graduate University of Advanced Technology, Kerman, Iran. m_adeli622002@yahoo.com.
Fereshteh Jabari-MoroueiDepartment of Food Science and Technology, Faculty of Agriculture Science and Research Branch, Islamic Azad University, Tehran, Iran.
Hamid ForootanfarDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran. h_forootanfar@kmu.ac.ir.

Funding

Mojtaba Shakibaie 400001142
6 · The paper itself

Abstract

In the present research, arsenic nanoparticles containing metformin (MTF@As NPs) were synthesized by subjecting a mixture of As

Indexed as

AntioxidantArsenic nanoparticles containing metforminCytotoxicityHemolysisMicrowave irradiation

Identifiers

PMID40156000
PMCPMC11954298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.